Skip to main content

Table 1 Clinical characteristics of patients with pulmonary tuberculosis

From: Decreased IL-17 during treatment of sputum smear-positive pulmonary tuberculosis due to increased regulatory T cells and IL-10

  HC (n = 20) AFB-positive TB patients (n = 20)
Age (years) 45 ± 21.9 (22–76) 55 ± 19.8 (18–86)
Sex (m/f) 12/8 13/7
Radiographic features
Infiltration 20/20 (100)
Cavitation 7/20(35)
Effusion 3/20 (15)
Smear grading
4+ 5/20 (25)
3+ 6/20 (30)
2+ 5/20 (25)
1+ 4/20 (20)
Resistance
Treatment HREZa 20/20 (100)
  1. aHERZ, isoniazid, ethambutol, rifampicin, plus pyrazinamide. Categorical variable data are presented as positive/tested (%). Continuous variable data are shown as mean ± SD (range)